KPP Advisory Services LLC Takes Position in HCA Healthcare, Inc. $HCA

KPP Advisory Services LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 567 shares of the company’s stock, valued at approximately $217,000.

Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at $1,021,000. GAMMA Investing LLC grew its position in HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock worth $1,704,000 after acquiring an additional 737 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in HCA Healthcare by 2.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock worth $1,491,000 after acquiring an additional 105 shares during the last quarter. Daymark Wealth Partners LLC grew its position in HCA Healthcare by 31.6% during the 1st quarter. Daymark Wealth Partners LLC now owns 3,703 shares of the company’s stock worth $1,280,000 after acquiring an additional 890 shares during the last quarter. Finally, Spire Wealth Management grew its position in HCA Healthcare by 7.5% during the 1st quarter. Spire Wealth Management now owns 10,658 shares of the company’s stock worth $3,683,000 after acquiring an additional 745 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $440.07 on Friday. The company has a market capitalization of $102.97 billion, a price-to-earnings ratio of 18.50, a P/E/G ratio of 1.39 and a beta of 1.40. The business’s 50-day moving average is $413.82 and its 200-day moving average is $380.88. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $447.09.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the business earned $5.50 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HCA. Royal Bank Of Canada reduced their price objective on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research report on Monday, July 28th. Wolfe Research downgraded HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Mizuho lifted their target price on HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Jefferies Financial Group lifted their target price on HCA Healthcare from $400.00 to $485.00 in a report on Wednesday, October 15th. Finally, Bank of America lifted their target price on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.